GlaxoSmithKline: all 4,196 studies
Page 41 of 42. Open to participants first (141), then studies with results posted, then the rest; newest registration first within each.
- A Efficacy Against Otitis Media in Children With 11 Valent Pneumococcal VaccineTerminatedNCT00119743Phase 3
- Ispinesib In Combination With Capecitabine In Patients With Solid TumorsCompletedNCT00119171Phase 1
- Study In Adolescent And Adult Subjects 12 Years Of Age And Older With Seasonal Allergic Rhinitis To Assess Onset of ActionCompletedNCT00118729Phase 3
- A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or ExerciseCompletedNCT00118690Phase 4
- A Study Of GW685698X For The Treatment Of Perennial Allergic Rhinitis In PediatricsCompletedNCT00116883Phase 3
- A Study of GW685698X for the Treatment Of Perennial Allergic Rhinitis in Adolescents and AdultsCompletedNCT00116818Phase 3
- A Study of Albuferon and Ribavirin in Interferon Naive Subjects With Chronic Hepatitis C Genotype 1CompletedNCT00115908Phase 2
- Study In Adults And Adolescents With Seasonal Allergic RhinitisCompletedNCT00115622Phase 3
- Advair® DISKUS® Versus Serevent® DISKUS® For Chronic Obstructive Pulmonary Disease ExacerbationsCompletedNCT00115492Phase 4
- Safety and Efficacy of an Antibody to CCR5 in Individuals With HIV Who Are Not Currently on Antiretroviral TherapyCompletedNCT00114699Phase 1
- Dental Pain (Following Third Molar Tooth Extraction) StudyCompletedNCT00114049Phase 3
- COX-2 Inhibitor Study In Patients With Rheumatoid ArthritisCompletedNCT00113308Phase 3
- Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial SeizuresCompletedNCT00113165Phase 3
- Study Of Lapatinib In Combination With Paclitaxel In The Treatment Of Newly Diagnosed Inflammatory Breast CancerCompletedNCT00111787Phase 2
- SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis CCompletedNCT00110799Phase 2
- Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal SprayCompletedNCT00109486Phase 3
- A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td VaccineCompletedNCT00109330Phase 3
- Perennial Allergic Rhinitis Study In Pediatric SubjectsCompletedNCT00108914Phase 3
- A Study To Evaluate An NK-1 Antiemetic For The Prevention Of Post Operative Nausea And VomitingCompletedNCT00108095Phase 2
- Seasonal Allergic Rhinitis In Pediatric SubjectsCompletedNCT00107757Phase 3
- Anti-Tumor Activity Of SB-485232 In Patients With Previously Untreated Metastatic MelanomaCompletedNCT00107718Phase 2
- Study Of Lapatinib In Patients With Relapsed Or Refractory Inflammatory Breast CancerCompletedNCT00105950Phase 2
- GW873140 In Combination With Combivir In HIV Infected SubjectsTerminatedNCT00104429Phase 2
- Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic ChemotherapyCompletedNCT00104403Phase 2
- Study In Subjects With COPD (Chronic Obstructive Pulmonary Disease)CompletedNCT00103922Phase 3
- Study Of Talnetant Versus Placebo And Risperidone In SchizophreniaCompletedNCT00103727Phase 2
- A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR).CompletedNCT00103454Phase 3
- Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol XinafoateCompletedNCT00102882Phase 4
- GW873140 In Combination With Kaletra In HIV Infected SubjectsTerminatedNCT00102778Phase 2
- Study Of Asthma In Patients Of African DescentCompletedNCT00102765Phase 4
- SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP)CompletedNCT00102739Phase 2
- SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving ChemotherapyCompletedNCT00102726Phase 2
- Study Of GW679769 In Major Depressive DisorderCompletedNCT00102492Phase 2
- Eight-Weeks Of Treatment With Talnetant In Subjects With Irritable Bowel Syndrome (IBS)CompletedNCT00101985Phase 2
- Nine-Weeks Treatment With 683699 In Subjects With Moderately-To-Severely Active Crohn's DiseaseCompletedNCT00101946Phase 2
- A Study of Albuferon With Ribavirin in Interferon Treatment Experienced Subjects With Chronic Hepatitis CCompletedNCT00097435Phase 2
- Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian CancerCompletedNCT00097409Phase 2
- Three Months Treatment With SB683699 In Patients With Relapsing Multiple SclerosisCompletedNCT00097331Phase 2
- Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)CompletedNCT00094848Phase 2
- Fosamprenavir Versus Other Protease InhibitorsCompletedNCT00094523Phase 3
- A Study Comparing Safety Of Abacavir And Lamivudine Administered Once-Daily As A Single Tablet Versus The Same Drugs Administered Twice-Daily As Separate Tablets (ALOHA Study)CompletedNCT00094367Phase 3
- HuMax-CD20 in Chronic Lymphocytic LeukemiaWithdrawnNCT00093314Phase 1/2
- Major Depressive Disorder In The ElderlyCompletedNCT00093288Phase 3
- Study of TRM-1(TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00092924Phase 2
- Study of HuMax-CD20, a New Drug to Treat Early Stage Non-Hodgkin´s Follicular LymphomaWithdrawnNCT00092274Phase 1/2
- Monotherapy Versus Placebo Over 7 Days-Non-Nucleoside Reverse Transcriptase Inhibitor-Experienced HIV1 Infected AdultsCompletedNCT00090077Phase 1
- Evaluation of 3APS in Patients With Mild to Moderate Alzheimer's DiseaseStatus unknownNCT00088673Phase 3
- Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES)CompletedNCT00086658Phase 3
- Study Of An FDA-approved Drug As Additional Therapy In Patients With SchizophreniaCompletedNCT00086593Phase 3
- KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 WeeksCompletedNCT00085943Phase 3
- Dose-Escalating Study Of SB-485232 Administered Intravenously Every 28 Days To Adults With Solid Tumors Or LymphomasCompletedNCT00085904Phase 1
- Dose-Escalation Study Of SB-485232 Administered As Daily Subcutaneous Injections In Adults With Solid TumorsCompletedNCT00085878Phase 1
- Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung CancerCompletedNCT00085813Phase 2
- A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIVCompletedNCT00082394Phase 4
- A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected PersonsTerminatedNCT00079911Phase 4
- A Study of Rituximab Versus Iodine I 131 Tositumomab Therapy for Patients With Non-Hodgkin's LymphomaStatus unknownNCT00078598Phase 3
- Capecitabine (XELODA) With Or Without Lapatinib (GW572016) For Women With Refractory Advanced or Metastatic Breast CancerCompletedNCT00078572Phase 3
- Clinical Study Of Schizophrenia in Both Men and WomenCompletedNCT00071747Phase 3
- Study Of AVANDAMET® With Or Without Insulin In Type II Diabetes Mellitus Patients. AVANDAMET® is a Registered Trademark of the GSK Group of Companies.CompletedNCT00069836Phase 3
- Seasonal Affective Depression (SAD) StudyCompletedNCT00069459Phase 1
- A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II DiabeticsCompletedNCT00067951Phase 3
- Bipolar Study in Adults at Least 18 Years of AgeCompletedNCT00067938Phase 4
- Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional TherapyCompletedNCT00067561Phase 3
- Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional TherapyCompletedNCT00067457Phase 3
- Depression Study In Elderly PatientsCompletedNCT00067444Phase 3
- Lethargic Depression StudyCompletedNCT00064467Phase 3
- OASIS-6 : The Safety and Efficacy of Fondaparinux Versus Control Therapy in Patients With ST Segment Elevation Acute Myocardial InfarctionCompletedNCT00064428Phase 3
- Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung CancerStatus unknownNCT00062907Phase 1
- Study of Untreated or Transformed Follicular Non-Hodgkin's Lymphoma With Fission-Derived Iodine I 131 TositumomabCompletedNCT00062894Phase 1/2
- Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) LevelsCompletedNCT00062790Phase 4
- GW572016 For Treatment Of Refractory Metastatic Breast CancerCompletedNCT00062686Phase 2
- Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal CancerCompletedNCT00061308Phase 2
- Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And HypertensionCompletedNCT00060931Phase 4
- Glycemic Control Of Carvedilol Versus Metoprolol In Patients With Type II Diabetes Mellitus And HypertensionCompletedNCT00060918Phase 4
- A Dose-escalation Vaccine Trial in HER2-overexpressing Patients With High-risk Breast CancerCompletedNCT00058526Phase 1
- An 8 Week Depression Study In Adults Diagnosed With Major Depressive DisorderCompletedNCT00057239Phase 2
- An 8 Week Study Of Adults Diagnosed With Major Depressive DisorderCompletedNCT00057226Phase 2
- An 8 Week Study Of Depression In Adults Diagnosed With Major Depressive DisorderCompletedNCT00057213Phase 2
- Bipolar Disorder Study for Men and WomenCompletedNCT00056277Phase 3
- Cerebril™ in Patients With Lobar Hemorrhage Related to Cerebral Amyloid AngiopathyCompletedNCT00056238Phase 2
- A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior TherapyCompletedNCT00053638Phase 3
- Effects Of Antidepressants On Sexual Functioning In AdultsCompletedNCT00051272Phase 3
- Effects of Antidepressants on Sexual FunctioningCompletedNCT00051259Phase 3
- Oral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin.CompletedNCT00051103Phase 2
- Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung CancerCompletedNCT00049998Phase 3
- Major Depressive Disorder Study In AdultsCompletedNCT00049972Phase 4
- Schizophrenia Study In AdultsCompletedNCT00049946Phase 2
- Attention-Deficit Hyperactivity Disorder (ADHD) Study With AdultsCompletedNCT00048360Phase 3
- A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive DisorderCompletedNCT00048204Phase 2
- Prevention of Seasonal Affective DisorderCompletedNCT00046449Phase 3
- A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected PatientsCompletedNCT00046332Phase 2
- Prevention of Seasonal Affective DisorderCompletedNCT00046241Phase 3
- A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced PatientsCompletedNCT00046176Phase 3
- A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid TumorsCompletedNCT00046111Phase 1
- New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected SubjectsCompletedNCT00044577Phase 3
- Efficacy and Safety In Poorly Controlled Type 2 DiabeticsCompletedNCT00044460Phase 4
- GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or OxaliplatinCompletedNCT00044343Phase 2
- Pediatric Epilepsy Study in Subjects 1-24 MonthsCompletedNCT00044278Phase 2
- Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive AdultsCompletedNCT00043927Phase 3
- Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With EpilepsyCompletedNCT00043914Phase 4